6% Hetastarch In 0.9% Sodium Chloride Injection, Solution
Product Images NDC 51662-1317

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for 6% Hetastarch In 0.9% Sodium Chloride (NDC 51662-1317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Label (51662 1317 1 Serialized Labeling Resized)

6% Hetastarch in 0.9% Sodium Chloride injection, solution in a 500 mL clear plastic intravenous bag with blue text labeling. The label states the active ingredient amount as 6 g/100 mL and specifies it is for intravenous use only. The product is labeled as prescription only by HF Acquisition Co LLC, DBA HealthFirst, located in Lake Forest, IL. The bag features two ports with colored caps and includes additional information on handling and usage instructions.*

FDA Label Image

Boxed Warning (Boxed Warning)

Text panel titled 'WARNING: MORTALITY RENAL REPLACEMENT THERAPY' warning that in critically ill adult patients, including those with sepsis, use of hydroxyethyl starch (HES) products like 6% Hetastarch in 0.9% Sodium Chloride Injection increases the risk of mortality and renal replacement therapy. Advises against using HES products in these patients.*

FDA Label Image

Container (Container Label)

Label for 6% Hetastarch in 0.9% Sodium Chloride Injection, solution for intravenous use. The label displays concentration (6 g/100 mL), volume markings up to 500 mL, and indicates single-dose use. It includes manufacturer information marked Hospira, Inc., and states Rx only. Additional details on storage, composition, and warnings appear in smaller text.*

FDA Label Image

Structure (Description)

Chemical structure of the active ingredient in 6% HETASTARCH IN 0.9% SODIUM CHLORIDE injection solution. The diagram shows a hexagonal ring with various oxygen and hydrogen atoms attached, representing the molecular layout of hetastarch.*

FDA Label Image

Boxed Warning (Highlights Boxed Warning)

A boxed warning panel titled 'WARNING: MORTALITY RENAL REPLACEMENT THERAPY' regarding the use of hydroxyethyl starch (HES) products, including 6% Hetastarch in 0.9% Sodium Chloride Injection. It highlights increased risks of mortality and renal replacement therapy in critically ill adult patients including those with sepsis, and advises against use in these patient groups.*

FDA Label Image

Dosage And Administration (Highlights D And A)

A table titled 'Recommended Dosage' listing doses for adults and leukapheresis. Adult dosage is 500 to 1000 mL. Leukapheresis dosage notes that 250 to 700 mL of 6% Hetastarch in 0.9% Sodium Chloride Injection with citrate anticoagulant is added to the centrifugation apparatus input line.*

FDA Label Image

How Supplied (How Supplied)

A data table listing units of sale and concentration for Hetastarch injection products. It shows one NDC (0409-7248-03) with a concentration of 30 g Hetastarch per 500 mL. It also notes a case containing 12 flexible plastic containers with a concentration of 6 g Hetastarch per 100 mL.*

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.